Clinical Trial Update: Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sofobuvir-containing regimens for chronic Hepatitis C across genotypes 1–6; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• sofosbuvir-containing regimens (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2016-09-16